INAB is currently covered by 1 analysts with an average price target of $6. This is a potential upside of $5.24 (689.47%) from yesterday's end of day stock price of $0.76.
In8bio's activity chart (see below) currently has 12 price targets and 27 ratings on display. The stock rating distribution of INAB is 100% BUY.
Analysts' price targets on this stock were met 36.67% of the time, taking 121.7 days on average.
Highest price target for INAB is $6, Lowest price target is $6, average price target is $6.
Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 04-Jun-2026. First documented stock forecast 23-Aug-2021.
Currently out of the existing stock ratings of INAB, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Aug-2022
$6
$4.95 (471.43%)
$6
5 months 17 days ago
(04-Jun-2026)
0/4 (0%)
$4.46 (289.61%)
Buy Since 13-Oct-2025
$4
1 years 1 months 8 days ago
(13-Oct-2025)
0/1 (0%)
$1.83 (84.33%)
Hold Since 11-Feb-2025
$6.5
1 years 9 months 10 days ago
(11-Feb-2025)
2/2 (100%)
$-26.2 (-80.12%)
335
Buy Since 18-Mar-2024
$7.5
$7.5
2 years 5 months 7 days ago
(14-Jun-2024)
3/3 (100%)
$-25.2 (-77.06%)
149
Buy Since 24-Aug-2021
$360
2 years 11 months 8 days ago
(13-Dec-2023)
0/2 (0%)
$239.4 (198.51%)
What is INAB (In8bio) average time for price targets to be met?
Which analyst most recently updated their price target on INAB (In8bio)?
Which analyst has the most public recommendations on INAB (In8bio)?
Which analyst is the currently most bullish on INAB (In8bio)?
Which analyst is the currently most reserved on INAB (In8bio)?